Joint Clinical Trials Office
Efficacy of Luspatercept In Clonal Cytopenias of Uncertain Significance
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 27, 2025
A prospective, multicenter, single-arm, non-randomized clinical study designed to evaluate the safety and effectiveness of the Citadel Embolization Device
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 24, 2025
Implantation Mycoses in Immunocompromised Patients: a retrospective review of disease course and treatment efficacy
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 13, 2025
Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 17, 2024
Habit Awareness Device for Treatment of Onychophagia
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
Comprehensive Assessment of Cancer Theranostics Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
A Phase 3, Randomized, Double-Blind, Placebo-Controlled study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
A randomized, double-blind, placebo-controlled study of LMN-201 for prevention of C. difficile infection recurrence (RePreve).
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 12, 2024
The Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair in Robotic Anti-Reflux Surgery: A Multi-Institutional Randomized Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 12, 2024